Endocannabinoid- and mGluR5-dependent short-term synaptic depression in an isolated neuron/bouton preparation from the hippocampal CA1 region

Journal of Neurophysiology

Volumn 100, Issue 2, 2008, Pages 1041-1052

  Sheinin, Anton ^a   Talani, Giuseppe ^a   Davis, Margaret I ^a   Lovinger, David M ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 3,5 DIHYDROXYPHENYLGLYCINE; 4 AMINOBUTYRIC ACID; ANANDAMIDE; CALCIUM; CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; GLUTAMATE RECEPTOR 5; NEUROTRANSMITTER; 2 ARACHIDONOYLGLYCEROL; 2-ARACHIDONYLGLYCEROL; 3,4 DIHYDROXYPHENYLETHYLENE GLYCOL; 4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 6 METHYL 2 (PHENYLETHYNYL)PYRIDINE; 6-METHYL-2-(PHENYLETHYNYL)PYRIDINE; ACYLGLYCEROL; AMINO ACID RECEPTOR BLOCKING AGENT; ARACHIDONIC ACID DERIVATIVE; BENZOXAZINE DERIVATIVE; DRUG DERIVATIVE; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR 5; MORPHOLINE DERIVATIVE; N (4 HYDROXYPHENYL)ARACHIDONYLAMIDE; N-(4-HYDROXYPHENYL)ARACHIDONYLAMIDE; NAPHTHALENE DERIVATIVE; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE; PYRIDINE DERIVATIVE; RIMONABANT; SYNAPSIN;

AMYGDALOID NUCLEUS; ANIMAL CELL; ARTICLE; CELL ISOLATION; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; DRUG INHIBITION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; NONHUMAN; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SYNAPTIC TRANSMISSION; ANIMAL; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; DRUG INTERACTION; IN VITRO STUDY; INHIBITORY POSTSYNAPTIC POTENTIAL; METABOLISM; METHODOLOGY; NERVE CELL; NEWBORN; PATCH CLAMP; PHYSIOLOGY; RADIATION EXPOSURE; RAT; SPRAGUE DAWLEY RAT; SYNAPSE;

ANIMALS; ANIMALS, NEWBORN; ARACHIDONIC ACIDS; BENZOXAZINES; DRUG INTERACTIONS; ENDOCANNABINOIDS; EXCITATORY AMINO ACID ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; GLYCERIDES; HIPPOCAMPUS; INHIBITORY POSTSYNAPTIC POTENTIALS; METHOXYHYDROXYPHENYLGLYCOL; MORPHOLINES; NAPHTHALENES; NEURONS; PATCH-CLAMP TECHNIQUES; PIPERIDINES; PYRAZOLES; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RECEPTORS, METABOTROPIC GLUTAMATE; SYNAPSES; SYNAPSINS;

EID: 55249119507     PISSN: 00223077     EISSN: 15221598     Source Type: Journal    
DOI: 10.1152/jn.90226.2008     Document Type: Article

References (37)

1. Akaike N, Moorhouse AJ. Techniques: applications of the nerve-bouton preparation in neuropharmacology. Trends Pharmacol Sci 24: 44-47, 2003.
2. Alger BE, Pitler TA, Wagner JJ, Martin LA, Morishita W, Kirov SA, Lenz RA. Retrograde signalling in depolarization-induced suppression of inhibition in rat hippocampal CA1 cells. J Physiol 496: 197-209, 1996.
3. Carlson G, Wang Y, Alger BE. Endocannabinoids facilitate the induction of LTP in the hippocampus. Nat Neurosci 5: 723-724, 2002.
4. De Petrocellis L, Bisogno T, Davis JB, Pertwee RG, Di Marzo V. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity. FEBS Lett 483: 52-56, 2000.
5. De Petrocellis L, Di Marzo V. Lipids as regulators of the activity of transient receptor potential type V1 (TRPV1) channels. Life Sci 77: 1651-1666, 2005.
6. Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC, Piomelli D. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372: 686-691, 1994.
7. Edwards DA, Kim J, Alger BE. Multiple mechanisms of endocannabinoid response initiation in hippocampus. J Neurophysiol 95: 67-75, 2006.
8. Glaser ST, Abumrad NA, Fatade F, Kaczocha M, Studholme KM, Deutsch DG. Evidence against the presence of an anandamide transporter. Proc Natl Acad Sci USA 100: 4269-4274, 2003.
9. Guo J, Ikeda SR. Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons. Mol Pharmacol 65: 665-674, 2004.
10. Hajos N, Katona I, Naiem SS, MacKie K, Ledent C, Mody I, Freund TF. Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur J Neurosci 12: 3239-3249, 2000.
11. Hampson RE, Zhuang SY, Weiner JL, Deadwyler SA. Functional significance of cannabinoid-mediated, depolarization-induced suppression of inhibition (DSI) in the hippocampus. J Neurophysiol 90: 55-64, 2003.
12. Hashimotodani Y, Ohno-Shosaku T, Maejima T, Fukami K, Kano M. Pharmacological evidence for the involvement of diacylglycerol lipase in depolarization-induced endocannabinoid release. Neuropharmacology 54: 58-67, 2008.
13. Herkenham M. Characterization and localization of cannabinoid receptors in brain: an in vitro technique using slide-mounted tissue sections. NIDA Res Monogr 112: 129-145, 1991.
14. Jung KM, Mangieri R, Stapleton C, Kim J, Fegley D, Wallace M, Mackie K, Piomelli D. Stimulation of endocannabinoid formation in brain slice cultures through activation of group I metabotropic glutamate receptors. Mol Pharmacol 68: 1196-1202, 2005.
15. 2+ release in sensory neurons. J Biol Chem 279: 16377-16387, 2004.
16. Katona I, Sperlagh B, Sik A, Kafalvi A, Vizi ES, Mackie K, Freund TF. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 19: 4544-4558, 1999.
17. Kim J, Isokawa M, Ledent C, Alger BE. Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus. J Neurosci 22: 10182-10191, 2002.
18. Kullmann DM, Asztely F. Extrasynaptic glutamate spillover in the hippocampus: evidence and implications. Trends Neurosci 21: 8-14, 1998.
19. Lichtman AH, Martin BR. Delta 9-tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism. Psychopharmacology (Berl) 126: 125-131, 1996.
20. Mackie K. Cannabinoid receptors as therapeutic targets. Annu Rev Pharmacol Toxicol 46: 101-122, 2006.
21. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561-564, 1990.
22. Ohno-Shosaku T, Maejima T, Kano M. Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 29: 729-738, 2001.
23. Ohno-Shosaku T, Shosaku J, Tsubokawa H, Kano M. Cooperative endocannabinoid production by neuronal depolarization and group I metabotropic glutamate receptor activation. Eur J Neurosci 15: 953-961, 2002.
24. Olah Z, Karai L, Iadarola MJ. Anandamide activates vanilloid receptor 1 (VR1) at acidic pH in dorsal root ganglia neurons and cells ectopically expressing VR1. J Biol Chem 276: 31163-31170, 2001.
25. Pacher P, Batkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58: 389-462, 2006.
26. Piomelli D. The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4: 873-884, 2003.
27. A responses in hippocampal pyramidal cells. J Neurosci 12: 4122-4132, 1992.
28. Pitler TA, Alger BE. Depolarization-induced suppression of GABAergic inhibition in rat hippocampal pyramidal cells: G protein involvement in a presynaptic mechanism. Neuron 13: 1447-1455, 1994.
29. Straiker A, Mackie K. Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones. J Physiol 569: 501-517, 2005.
30. 2+ influx via TRPV1 channels. EMBO J 24: 3026-3037, 2005.
31. Vandevoorde S, Fowler CJ. Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate. Br J Pharmacol 145: 885-893, 2005.
32. Varma N, Carlson GC, Ledent C, Alger BE. Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. J Neurosci 21: RC188, 2001.
33. Vorobjev VS. Vibrodissociation of sliced mammalian nervous tissue. J Neurosci Methods 38: 145-150, 1991.
34. Wilson RI, Nicoll RA. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410: 588-592, 2001.
35. Zhu PJ, Lovinger DM. Retrograde endocannabinoid signaling in a postsynaptic neuron/synaptic bouton preparation from basolateral amygdala. J Neurosci 25: 6199-6207, 2005.
36. Zygmunt PM, Chuang H, Movahed P, Julius D, Hogestatt ED. The anandamide transport inhibitor AM404 activates vanilloid receptors. Eur J Pharmacol 396: 39-42, 2000.
37. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, Di Marzo V, Julius D, Hogestatt ED. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400: 452-457, 1999.